CAPS Financials 07/16/2014 03:38:07
Capstone Therapeutics Corp
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 3,124 2,385 6,394 8,168
Sales, General and Admin. 1,169 1,764 3,506 3,240
Non-Recurring Items - - - -
Other - - - -
Operating Income (4,293) (4,149) (9,900) (11,408)
Income From Continuing Operations
Add'l Income/Expense Items 158 96 31 356
Earnings Before Interest and Tax (4,135) (4,053) (9,869) (11,052)
Interest Expense - - - -
Earnings Before Tax (4,135) (4,053) (9,869) (11,052)
Income Tax (21) - (158) (181)
Minority Interest (193) (473) - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,114) (4,053) (9,711) (10,871)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,921) (3,580) (9,711) (10,871)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (3,921) (3,580) (9,711) (10,871)
Capstone Therapeutics Corp
Period Ending Dec 31, 2013 Dec 31, 2012 Dec 31, 2011 Dec 31, 2010
Total Revenue - - - -
Cost of Revenue - - - -
Gross Profit - - - -
Operating Expenses
Research and Development 3,124 2,385 6,394 8,168
Sales, General and Admin. 1,169 1,764 3,506 3,240
Non-Recurring Items - - - -
Other - - - -
Operating Income (4,293) (4,149) (9,900) (11,408)
Income From Continuing Operations
Add'l Income/Expense Items 158 96 31 356
Earnings Before Interest and Tax (4,135) (4,053) (9,869) (11,052)
Interest Expense - - - -
Earnings Before Tax (4,135) (4,053) (9,869) (11,052)
Income Tax (21) - (158) (181)
Minority Interest (193) (473) - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations (4,114) (4,053) (9,711) (10,871)
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income (3,921) (3,580) (9,711) (10,871)
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders (3,921) (3,580) (9,711) (10,871)
